ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients

被引：0
|
作者：
Chen, Zongshun [1 ,2 ]
Zhang, Jing [3 ]
Chen, Wei [1 ,2 ]
Chen, Xueyi [2 ,4 ]
Lu, Da-Lin [3 ]
Li, Junjie [2 ]
机构：
[1] Chengdu Univ Tradit Chinese Med, Sch Med & Life Sci, Chengdu, Peoples R China
[2] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Clin Res Ctr Canc, Sichuan Canc Ctr,Dept Breast Surg, Chengdu, Peoples R China
[3] Jinan Univ, Sch Med, Dept Epidemiol, Jinan, Guangdong, Peoples R China
[4] Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Clin Res Ctr Canc, Dept Breast Surg,Sch Med,Sichuan Canc Ctr, Chengdu, Peoples R China
来源：
ANNALS OF SURGICAL ONCOLOGY | 2025年
关键词：
D O I：
10.1245/s10434-025-17243-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4061 / 4062
页数：2
相关论文
共 50 条
  • [21] Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'
    Altundag, Kadri
    BRITISH JOURNAL OF CANCER, 2017, 116 (08) : e10 - e10
  • [22] Association between pathologic complete response and biochemical indicators after neoadjuvant therapy for HER2-positive breast cancer
    Chen, Wei
    Zhang, Jing
    Li, Fenxiang
    Chen, Zongshun
    Li, Junjie
    Lu, Da-Lin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [23] Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’
    Kadri Altundag
    British Journal of Cancer, 2017, 116 : e10 - e10
  • [24] ASO Visual Abstract: Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor Positive Breast Cancer Patients—Pathologic and Surgical Outcomes
    Lifen Cao
    Kavin Sugumar
    Eleanor Keller
    Pamela Li
    Lisa Rock
    Ashley Simpson
    Alberto J. Montero
    Mary Freyvogel
    Robert Shenk
    Megan E. Miller
    Annals of Surgical Oncology, 2021, 28 : 657 - 658
  • [25] High Pathologic Complete Response in Her2-Positive, Early-Stage Breast Cancer to a Novel Nonanthracycline Neoadjuvant Chemotherapy
    Zelnak, Amelia B.
    Nikolinakos, Petros
    Srinivasiah, Jayanthi
    Jonas, William
    Pippas, Andrew
    Liu, Yuan
    Li, Xiaoxian
    Torres, Mylin
    O'Regan, Ruth M.
    CLINICAL BREAST CANCER, 2015, 15 (01) : 31 - 36
  • [26] Pathologic Complete Response to Neoadjuvant Chemotherapy Plus Trastuzumab Predicts for Improved Survival in Women With HER2-positive Breast Cancer
    Kim, M. M.
    Allen, P.
    Gonzalez-Angulo, A.
    Woodward, W. A.
    Meric-Bernstam, F.
    Buzdar, A. U.
    Hunt, K. K.
    Hortobagyi, G. N.
    Buchholz, T. A.
    Mittendorf, E. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S229 - S229
  • [27] Pathologic complete response (pCR) and prognosis following neoadjuvant chemotherapy plus anti-HER2 therapy of HER2-positive early breast cancer (EBC)
    Loibl, Sibylle
    Untch, Michael
    Buyse, Marc
    Robidoux, Andre
    Gianni, Luca
    Schneeweiss, Andreas
    Conte, Pierfranco
    Piccart, Martine
    Bonnefoi, Herve
    Jackisch, Christian
    Nekljudova, Valentina
    Costantino, Joseph
    Valagussa, Pinuccia
    Neate, Colin
    Gelber, Richard
    Poncet, Coralie
    Squifflet, Pierre
    Saad, Everardo
    Heinzmann, Dominik
    Denkert, Carsten
    Geyer, Charles E., Jr.
    Cortes, Javier
    Guarneri, Valentina
    de Azambuja, Evandro
    Cameron, David
    Ismael, Gustavo
    von Minckwitz, Gunter
    Wolmark, Norman
    Cortazar, Patricia
    CANCER RESEARCH, 2020, 80 (04)
  • [28] Reply to 'Comment on 'Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy''
    Fujii, Takeo
    Ueno, Naoto T.
    BRITISH JOURNAL OF CANCER, 2017, 116 (08) : e11 - e11
  • [29] Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy’’
    Takeo Fujii
    Naoto T Ueno
    British Journal of Cancer, 2017, 116 : e11 - e11
  • [30] ASO Visual Abstract: Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor Positive Breast Cancer Patients-Pathologic and Surgical Outcomes
    Cao, Lifen
    Sugumar, Kavin
    Keller, Eleanor
    Li, Pamela
    Rock, Lisa
    Simpson, Ashley
    Montero, Alberto J.
    Freyvogel, Mary
    Shenk, Robert
    Miller, Megan E.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 657 - 658
12345